Therapeutic Areas

AcelaBio is improving patient health by providing clinical research services in the field of histopathology and precision medicine for GI diseases.

AcelaBio supports clinical trials and clinical research of gastrointestinal disease including, but not limited to, inflammatory bowel disease (IBD), eosinophilic esophagitis (EoE), nonalcoholic steatohepatitis (NASH), and celiac disease (CeD) through:

  • Highly trained and experienced Histology Team
  • Pathology review by experienced and board-certified Pathologists
  • State-of-the-art equipment for sample processing, embedding, sectioning, staining
  • Compliant laboratory facility for processing samples
    • 21CFR Part 11 compliant laboratory information system
    • Whole slide imaging with a medical device approved scanner
    • 21CFR Part 11 compliant image management system
  • Innovative technologies for biomarker assessment, including immunostaining and multiplexing
  • Quantitative digital image analysis
  • Consultation services supporting all stages of clinical development
  • Strategic partnerships with global leaders in GI